The York Research Database
- » Research
- » York Research Database
- » Publications
- » Coverage with evidence development, only in research, risk sharing or ...
Coverage with evidence development, only in research, risk sharing or patient access scheme? A framework for coverage decisions
Research output: Book/Report › Other report
Full text download(s)
CHERP77_a_framework_for_coverage_decisions_only_in_research_evidence_development
476 KB, PDF document
Links
Author(s)
Department/unit(s)
Publication details
| Date | Published - Apr 2012 |
|---|---|
| Number of pages | 40 |
| Publisher | Centre for Health Economics, University of York |
| Place of Publication | York UK |
| Volume | 77 |
| Original language | English |
Publication series
| Name | CHE Research Paper |
|---|---|
| Publisher | Centre for Health Economics, University of York |
| No. | 77 |
Abstract
Until recently, purchasers’ options regarding whether to pay for the use of technologies have been binary in nature: a treatment is covered or not covered. However, policies have emerged which expand the options - for example, linking coverage to evidence development, an option increasingly used for new treatments with limited/uncertain evidence. There has been little effort to reconcile the features of technologies with the available options in a way that reflects purchasers’ ranges of authority
- health technology assessment, cost effectiveness, comparative effectiveness, only in research, coverage with evidence development, patient access scheme
Research areas
Discover related content
Find related publications, people, projects, datasets and more using interactive charts.